HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$3.37
Day range
$3.03 - $3.42
Year range
$2.23 - $6.89
Market cap
514.04M USD
Avg Volume
2.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | -44.00K | -10.00% |
Operating expense | 17.22M | -17.99% |
Net income | -89.26M | 13.03% |
Net profit margin | 202.86K | -20.94% |
Earnings per share | -0.51 | 22.73% |
EBITDA | -68.45M | 26.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 448.70M | -13.27% |
Total assets | 642.84M | -21.76% |
Total liabilities | 130.60M | -15.57% |
Total equity | 512.23M | — |
Shares outstanding | 169.09M | — |
Price to book | 1.11 | — |
Return on assets | -26.54% | — |
Return on capital | -27.94% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -89.26M | 13.03% |
Cash from operations | -53.71M | 13.51% |
Cash from investing | 67.46M | 36.02% |
Cash from financing | 155.00K | 236.96% |
Net change in cash | 13.91M | 211.69% |
Free cash flow | -29.65M | 6.33% |
About
Founded
2017
Headquarters
Website
Employees
232